🚀 VC round data is live in beta, check it out!
KORU Medical Systems Valuation Multiples
Discover revenue and EBITDA valuation multiples for KORU Medical Systems and similar public comparables like Paragon Care, Bastide Le Confort Médical, Tristel, Prim and more.
KORU Medical Systems Overview
About KORU Medical Systems
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
Founded
1980
HQ
Employees
83
Website
Sectors
Financials (LTM)
EV
$217M
KORU Medical Systems Financials
KORU Medical Systems reported last 12-month revenue of $43M and EBITDA of $1M.
In the same LTM period, KORU Medical Systems generated $27M in gross profit, $1M in EBITDA, and had net loss of ($2M).
Revenue (LTM)
KORU Medical Systems P&L
In the most recent fiscal year, KORU Medical Systems reported revenue of $41M and EBITDA of $652K.
KORU Medical Systems expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $43M | XXX | $41M | XXX | XXX | XXX |
| Gross Profit | $27M | XXX | $26M | XXX | XXX | XXX |
| Gross Margin | 62% | XXX | 62% | XXX | XXX | XXX |
| EBITDA | $1M | XXX | $652K | XXX | XXX | XXX |
| EBITDA Margin | 2% | XXX | 2% | XXX | XXX | XXX |
| EBIT Margin | (6%) | XXX | (7%) | XXX | XXX | XXX |
| Net Profit | ($2M) | XXX | ($3M) | XXX | XXX | XXX |
| Net Margin | (6%) | XXX | (6%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
KORU Medical Systems Stock Performance
KORU Medical Systems has current market cap of $221M, and enterprise value of $217M.
Market Cap Evolution
KORU Medical Systems' stock price is $4.78.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $217M | $221M | 0.0% | XXX | XXX | XXX | $-0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialKORU Medical Systems Valuation Multiples
KORU Medical Systems trades at 5.1x EV/Revenue multiple, and 212.6x EV/EBITDA.
EV / Revenue (LTM)
KORU Medical Systems Financial Valuation Multiples
As of March 28, 2026, KORU Medical Systems has market cap of $221M and EV of $217M.
Equity research analysts estimate KORU Medical Systems' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
KORU Medical Systems has a P/E ratio of (94.5x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $221M | XXX | $221M | XXX | XXX | XXX |
| EV (current) | $217M | XXX | $217M | XXX | XXX | XXX |
| EV/Revenue | 5.1x | XXX | 5.3x | XXX | XXX | XXX |
| EV/EBITDA | 212.6x | XXX | 332.3x | XXX | XXX | XXX |
| EV/EBIT | (80.0x) | XXX | (72.9x) | XXX | XXX | XXX |
| EV/Gross Profit | 8.1x | XXX | 8.5x | XXX | XXX | XXX |
| P/E | (94.5x) | XXX | (83.9x) | XXX | XXX | XXX |
| EV/FCF | 2432.9x | XXX | (438.5x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified KORU Medical Systems Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
KORU Medical Systems Margins & Growth Rates
KORU Medical Systems' revenue in the last 12 month grew by 18%.
KORU Medical Systems' revenue per employee in the last FY averaged $0.5M.
KORU Medical Systems' rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
KORU Medical Systems' rule of X is 47% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
KORU Medical Systems Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 18% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Margin | 2% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Growth | 196% | XXX | 239% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 20% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 47% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 11% | XXX | 11% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 70% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
KORU Medical Systems Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Paragon Care | XXX | XXX | XXX | XXX | XXX | XXX |
| Bastide Le Confort Médical | XXX | XXX | XXX | XXX | XXX | XXX |
| Tristel | XXX | XXX | XXX | XXX | XXX | XXX |
| Prim | XXX | XXX | XXX | XXX | XXX | XXX |
| Stille | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
KORU Medical Systems M&A Activity
KORU Medical Systems acquired XXX companies to date.
Last acquisition by KORU Medical Systems was on XXXXXXXX, XXXXX. KORU Medical Systems acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by KORU Medical Systems
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialKORU Medical Systems Investment Activity
KORU Medical Systems invested in XXX companies to date.
KORU Medical Systems made its latest investment on XXXXXXXX, XXXXX. KORU Medical Systems invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by KORU Medical Systems
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout KORU Medical Systems
| When was KORU Medical Systems founded? | KORU Medical Systems was founded in 1980. |
| Where is KORU Medical Systems headquartered? | KORU Medical Systems is headquartered in United States. |
| How many employees does KORU Medical Systems have? | As of today, KORU Medical Systems has over 83 employees. |
| Who is the CEO of KORU Medical Systems? | KORU Medical Systems' CEO is Linda M. Tharby. |
| Is KORU Medical Systems publicly listed? | Yes, KORU Medical Systems is a public company listed on Nasdaq. |
| What is the stock symbol of KORU Medical Systems? | KORU Medical Systems trades under KRMD ticker. |
| When did KORU Medical Systems go public? | KORU Medical Systems went public in 1996. |
| Who are competitors of KORU Medical Systems? | KORU Medical Systems main competitors are Paragon Care, Bastide Le Confort Médical, Tristel, Prim. |
| What is the current market cap of KORU Medical Systems? | KORU Medical Systems' current market cap is $221M. |
| What is the current revenue of KORU Medical Systems? | KORU Medical Systems' last 12 months revenue is $43M. |
| What is the current revenue growth of KORU Medical Systems? | KORU Medical Systems revenue growth (NTM/LTM) is 18%. |
| What is the current EV/Revenue multiple of KORU Medical Systems? | Current revenue multiple of KORU Medical Systems is 5.1x. |
| Is KORU Medical Systems profitable? | Yes, KORU Medical Systems is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of KORU Medical Systems? | KORU Medical Systems' last 12 months EBITDA is $1M. |
| What is KORU Medical Systems' EBITDA margin? | KORU Medical Systems' last 12 months EBITDA margin is 2%. |
| What is the current EV/EBITDA multiple of KORU Medical Systems? | Current EBITDA multiple of KORU Medical Systems is 212.6x. |
| What is the current FCF of KORU Medical Systems? | KORU Medical Systems' last 12 months FCF is $89K. |
| What is KORU Medical Systems' FCF margin? | KORU Medical Systems' last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of KORU Medical Systems? | Current FCF multiple of KORU Medical Systems is 2432.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.